Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Egalet Corp (EGLT)

Egalet Corp (EGLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 1,788
  • Shares Outstanding, K 56,770
  • Annual Sales, $ 26,140 K
  • Annual Income, $ -69,360 K
  • 60-Month Beta 0.64
  • Price/Sales 0.19
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade EGLT with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.16
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/14/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.21
  • Number of Estimates 1
  • High Estimate -0.21
  • Low Estimate -0.21
  • Prior Year -0.46
  • Growth Rate Est. (year over year) +54.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0310 +1.61%
on 10/31/18
0.1580 -80.06%
on 10/05/18
-0.0926 (-74.62%)
since 09/28/18
3-Month
0.0310 +1.61%
on 10/31/18
0.6800 -95.37%
on 08/07/18
-0.2465 (-88.67%)
since 07/30/18
52-Week
0.0310 +1.61%
on 10/31/18
1.5700 -97.99%
on 11/16/17
-0.9685 (-96.85%)
since 10/30/17

Most Recent Stories

More News
Pain Relief Therapeutics Market 2021 Opportunity Assessment, Business Opportunities, Top Industry Players, Trend and Growth to 2027

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)
US Pain Relief Therapeutics Market Share 2021 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2027

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
VRX.TO : 30.80 (-3.33%)
Pain Relief Therapeutics Market Share 2020 : Growth Opportunities with Covid-19 Impact Analysis, Business Structure with Top Key Players Size, Development Plans and Challenges Forecast to 2026

The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
SRNE : 8.09 (-2.06%)
VRX.TO : 30.80 (-3.33%)
Pain Relief Therapeutics Market 2020 Global Industry Analysis, Size, Share, Growth, Trends, and Forecast to 2025

Brandessece Market Research recently added the research report which offers a thorough study of the market scenario regarding the market size, share, demand, growth, trends, and forecast from 2020-2026....

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
SRNE : 8.09 (-2.06%)
VRX.TO : 30.80 (-3.33%)
Nasal Sprays Market to Expand, Growth Pivoted by Applications in Drug Delivery System, says Fortune Business Insights

The global nasal sprays market is slated to witness accelerated growth with increasing regulatory approvals for newer products. According to a report by Fortune Business Insights, titled "Nasal Spray Market...

AGN : 193.02 (+0.02%)
BAYRY : 14.9200 (-1.33%)
EGLT : 0.0315 (-63.37%)
GSK : 39.52 (+1.28%)
INNV : 16.61 (+0.24%)
The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028

, /PRNewswire/ -- The global opioids drugs market is anticipated to grow at a CAGR of 2.48% over the forecast period of 2019-2028. The major factors augmenting the global market growth are the growing...

ACUR : 0.6200 (-10.61%)
AGN : 193.02 (+0.02%)
BDSI : 3.64 (+0.55%)
COLL : 24.76 (+0.61%)
EGLT : 0.0315 (-63.37%)
HKMPF : 36.0000 (+0.86%)
LCI : 4.61 (-3.35%)
PFE : 42.10 (+0.69%)
TEVA : 8.92 (-0.22%)
Pain Relief Therapeutics Market 2019 Industry Analysis and Opportunities by Top Key Players are Novartis AG, Eli Lilly & Company, Abbott Laboratories, Endo Health Solutions Inc., Purdue Pharma L.P.

: The rising prevalence of chronic diseases such as a variety of cancers, osteoarthritis, stomach ulcer, chronic arthritis and diabetes are major key factor which drives the Global Pain Relief Therapeutics...

ABT : 119.81 (+0.24%)
ACRX : 1.1900 (-1.65%)
ACOR : 3.96 (-7.69%)
AXSM : 52.66 (+1.68%)
BAYRY : 14.9200 (-1.33%)
BDRFF : 119.7000 (unch)
BDSI : 3.64 (+0.55%)
BMY : 67.49 (-0.30%)
COLL : 24.76 (+0.61%)
DEPO : 7.30 (+1.67%)
DRRX : 1.3600 (-1.45%)
EGLT : 0.0315 (-63.37%)
LLY : 243.58 (+0.15%)
FLXN : 6.14 (-1.13%)
GLPG : 60.37 (+0.48%)
HRTX : 12.24 (-2.47%)
KMPH : 10.76 (+0.09%)
MRK : 77.85 (+0.79%)
MESO : 7.04 (-1.68%)
NKTR : 15.91 (-2.03%)
NVS : 91.32 (+0.40%)
ORXOY : 4.4499 (-1.55%)
PFE : 42.10 (+0.69%)
REGN : 581.01 (+0.56%)
SRNE : 8.09 (-2.06%)
VRX.TO : 30.80 (-3.33%)
Egalet Reports First Quarter 2019 Financial Results and Plan to Change Company Name to Zyla Life Sciences

Egalet Corporation (OTCQX: ZCOR) ("Egalet"), a growing commercial-stage life sciences company, today reported financial results for the first quarter ended March 31, 2019 and announced it will change its...

EGLT : 0.0315 (-63.37%)
ZCOR : 2.0500 (+2.50%)
Egalet to Host Conference Call and Webcast to Discuss First Quarter 2019 Financial Results on May 16, 2019

Egalet Corporation (OTCQX: ZCOR) ("Egalet"), a commercial-stage life sciences company focused on marketing treatments for different types of pain and inflammation, today announced that its first quarter...

EGLT : 0.0315 (-63.37%)
ZCOR : 2.0500 (+2.50%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 0.1232
1st Resistance Point 0.0773
Last Price 0.0315
1st Support Level 0.0083
2nd Support Level 0.0000
3rd Support Level N/A

See More

52-Week High 1.5700
Fibonacci 61.8% 0.9821
Fibonacci 50% 0.8005
Fibonacci 38.2% 0.6189
Last Price 0.0315
52-Week Low 0.0310

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar